Show simple item record

dc.contributor.authorHidalgo Figueroa, María
dc.contributor.authorSalazar, Alejandro
dc.contributor.authorRomero López Alberca, Cristina
dc.contributor.authorMacDowell, Karina S.
dc.contributor.authorGarcía Bueno, Borja
dc.contributor.authorBioque, Miquel
dc.contributor.authorBernardo, Miquel
dc.contributor.authorParellada, Mara
dc.contributor.authorGonzález Pinto Arrillaga, Ana María ORCID
dc.contributor.authorGarcía Portilla, María Paz
dc.contributor.authorLobo, Antonio
dc.contributor.authorRodríguez Jiménez, Roberto
dc.contributor.authorBerrocoso, Esther
dc.contributor.authorLeza, Juan Carlos
dc.date.accessioned2022-09-30T16:39:45Z
dc.date.available2022-09-30T16:39:45Z
dc.date.issued2022-08
dc.identifier.citationInternational Journal of Neuropsychopharmacology 25(8) : 666-677 (2022)es_ES
dc.identifier.issn1461-1457
dc.identifier.issn1469-5111
dc.identifier.urihttp://hdl.handle.net/10810/57892
dc.description.abstractBackground Approximately 3% of the population suffers a first episode of psychosis (FEP), and a high percentage of these patients subsequently relapse. Because the clinical course following a FEP is hard to predict, it is of interest to identify cognitive and biological markers that will help improve the diagnosis, treatment, and outcome of such events and to define new therapeutic targets. Here we analyzed the plasma oxytocin and prolactin levels during an FEP, assessing their correlation with clinical and cognitive features. Methods The oxytocin and prolactin in plasma was measured in 120 FEP patients and 106 healthy controls, all of whom were subjected to a clinical and neuropsychological assessment. Most patients were under antipsychotics. Statistical analyses aimed to identify factors associated with the FEP and to search for associations between the variables. This study is preliminary and exploratory because the P-values were not corrected for multiple comparisons. Results FEP patients had less oxytocin, more prolactin, and a poor premorbid IQ, and they performed worse in sustained attention. Male patients with higher prolactin levels experienced more severe psychotic symptoms and required higher doses of antipsychotics. Low oxytocin was associated with poor sustained attention in women, whereas low oxytocin and high prolactin in men correlated with better performance in sustained attention. Conclusion Low oxytocin, high prolactin, and poor premorbid IQ and sustained attention are factors associated with an FEP, representing potential therapeutic targets in these patients. These biological factors and cognitive domains might play an important role during a FEP, which could help us to develop new strategies that improve the outcomes of this disorder and that should perhaps be gender specific.es_ES
dc.description.sponsorshipThis work was supported by CIBERSAM Intramural Projects 2010 (P02) "Flamm- PEPs, inflammatory alterations in schizophrenia: search of biological markers in first-psychotic episodes," Spanish Ministry of Economy and Competiveness, Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias (PI1100325). R.R.J. was supported by the Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias/FEDER (PI19/00766) and by the Madrid Regional Government (S2017/BMD-3740). M.P.G.-P. was supported by the Government of the Principality of Asturias (PCTI-2018-2022 IDI/2018/235). M.H.-F. was supported by the 2014-2020 ERDF Operational Programme and by the Department of Economy, Knowledge, Business and University of the Regional Government of Andalusia (FEDER-UCA18-106933).es_ES
dc.language.isoenges_ES
dc.publisherOxford University Presses_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.subjectfirst-episode psychosises_ES
dc.subjectoxytocines_ES
dc.subjectprolactines_ES
dc.subjectcognitiones_ES
dc.subjectsexual dimorphismes_ES
dc.titleThe Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performancees_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2022, Oxford University Press. This article is available under the Creative Commons CC-BY-NC license and permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.es_ES
dc.rights.holderAtribución-NoComercial 3.0 España*
dc.relation.publisherversionhttps://academic.oup.com/ijnp/article/25/8/666/6556066?login=truees_ES
dc.identifier.doi10.1093/ijnp/pyac023
dc.departamentoesNeurocienciases_ES
dc.departamentoeuNeurozientziakes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2022, Oxford University Press. This article is available under the Creative Commons CC-BY-NC license and permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's license is described as © 2022, Oxford University Press. This article is available under the Creative Commons CC-BY-NC license and permits non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.